Apoptotic index in ovarian carcinoma: Correlation with clinicopathologic factors and prognosis

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 439-448

  Yamasaki, Fumio ^a   Tokunaga, Osamu ^a   Sugimori, Hajime ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DEATH; CLINICAL PROTOCOL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS INDEX; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

EID: 0031239939     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4783     Document Type: Article

References (37)

1. 1. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972
2. 2. Duvall E, Wyllie AH: Death and the cell. Immunol Today 7:115-119, 1986
3. 3. Kerr JFR, Searle J, Harmon BV, Bishop CJ: Apoptosis, in Potten CS (eds): Perspectives on Mammalian Cell Death. London, Oxford Univ. Press, 1987, pp 93-128
4. 4. Wyllie AH: Apoptosis: Cell death under homeostasic control. Arch Toxicol 11:3-10, 1987
5. 5. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 73:2013-2036, 1994
6. 6. Leoncini L, Del Vecchio MT, Megha T, Barbini P, Galieni P, Gherlinzoni F, Tosi P, Kraft R, Cottier H: Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 142:755-763, 1993
7. 7. Lipponen PK, Aaltomaa S, Kosma VM, Syrjanen K: Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30:2068-2073, 1994
8. 8. Lipponen PK, Aaltomaa S: Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 173:333-339, 1994
9. 9. Aihara M, Truong LD, Dunn JK, Wheeler M, Scardino PT, Thompson TC: Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol 25:797-801, 1994
10. 10. Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, Thompson TC: The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 75:522-529, 1995
11. 11. Wheeler JA, Stephens LC, Tornos C, Eifel PJ, Ang KK, Milas L, Allen PK, Meyn RE: ASTRO Research Fellowship: Apoptosis as a predictor of tumor response to radiation in stage Ib cervical carcinoma. Int J Radiat Oncol Biol Phys 32:1487-1493, 1995
12. 12. Chyle V, Pollack A, Czerniak B, Stephens LC, Zagars GK, Terry NH, Meyn RE: Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 35:281-287, 1996
13. 13. Diebold J, Baretton G, Felchner M, Meier W, Dopfer K, Schmidt M, Lohrs U: bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinoma. Am J Clin Pathol 105:341-349, 1996
14. 14. Lane DP: A death in the life of p53. Nature 362:786-787, 1993
15. 15. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299, 1995
16. 16. Oltvai ZN, Milliman CL, Korsmeyer SJ: bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619, 1993
17. 17. Serov SE, Scully RE, Sobin LH: Histological Typing of Ovarian Tumors, World Health Organization, Geneva, Switzerland, 1973, pp 37-42
18. 18. Kennedy AW, Biscotti CV, Hart WR, Tuason LJ: Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma. Gynecol Oncol 50:334-338, 1993
19. 19. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
20. 20. White E: Tumor biology, p53, guardian of Rb. Nature 371:21-22, 1994
21. 21. Havrilesky LJ, Elbendary A, Hurteau JA, Whitaker RS, Rodriguez GC, Berchuck A: Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet Gynecol 85:1007-1010, 1995
22. 22. Kiberu SW, Pringle JH, Murphy P, Lauder I: Correlation between apoptosis, proliferation and bcl-2 expression in malignant non-Hodgkin's lymphoma. J Clin Pathol Mol Pathol 49:268-272, 1996
23. 23. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992
24. 24. Evan GI, Littlewood TD: The role of c-myc in cell growth. Curr Opin Genet Dev 3:44-49, 1993
25. 25. Koshinen PJ, Alitaro K: Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol 4:3-12, 1993
26. 26. Stewart BW: Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators, J Natl Cancer Inst 86:1286-1296, 1994
27. 27. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH: Premature P34cdc2 activation required for apoptosis. Science 263:1143-1145, 1994
28. 28. Henriksen R, Wilander E, Oberg K: Expression and prognostic significance of Bcl-2 in ovarian tumours. Brit J Cancer 72:1324-1329, 1995
29. 29. Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS, Kerr DJ: The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res 56:2178-2184, 1996
30. 30. Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994
31. 31. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY: Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
32. 2+ concentration and DNA fragmentation. Cancer Res 52:1342-1346, 1992
33. 33. Moss DJ, Burrows SR, Baxter GD, Lavin MF: T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism. J Exp Med 173:681-686, 1991
34. 34. Baretton GB, Diebold J, Christoforis G, Vogt M, Muller C, Dopfer K, Schneiderbanger K, Schmidt M, Lohrs U: Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer 77:255-264, 1996
35. 35. Monaghan P, Robertson D, Amos AS, Dyer MJS, Mason DY, Greaves MF: Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 40:1819-1825, 1992
36. 36. Chou SK, Rao L, White E: bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556-2563, 1994
37. 37. Wang Y, Szekely L, Okan I, Klein G, Wiman G: Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 8:3427-3431, 1993